Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-19
DOI
10.1111/jdv.15075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cutaneous T-cell Lymphoma and Pruritus: The Expression of IL-31 and its Receptors in the Skin
- (2016) L Nattkemper et al. ACTA DERMATO-VENEREOLOGICA
- The pruritus- and T H 2-associated cytokine IL-31 promotes growth of sensory nerves
- (2016) Micha Feld et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mast Cells Are Abundant in Primary Cutaneous T-Cell Lymphomas: Results from a Computer-Aided Quantitative Immunohistological Study
- (2016) Johanna Eder et al. PLoS One
- Il-31 Does not Correlate to Pruritus Related to Early Stage Cutaneous T-cell Lymphomas but is Involved in Pathogenesis of the Disease
- (2015) M Malek et al. ACTA DERMATO-VENEREOLOGICA
- Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities
- (2015) Filiberto Cedeno-Laurent et al. CLINICAL IMMUNOLOGY
- Analysis of the IL-31 pathway in Mycosis fungoides and Sézary syndrome
- (2014) Markus Möbs et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice
- (2014) Iwao Arai et al. EXPERIMENTAL DERMATOLOGY
- Serum IL-31 Levels are Increased in Patients with Cutaneous T-cell Lymphoma
- (2013) H Ohmatsu et al. ACTA DERMATO-VENEREOLOGICA
- Association of Nerve Growth Factor, Chemokine (C-C motif) Ligands and Immunoglobulin E with Pruritus in Cutaneous T-cell Lymphoma
- (2013) H Suga et al. ACTA DERMATO-VENEREOLOGICA
- Interleukin-31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge
- (2013) T. Hawro et al. ALLERGY
- Potential New Therapeutic Targets for Pathological Pruritus
- (2013) Yasushi Kuraishi BIOLOGICAL & PHARMACEUTICAL BULLETIN
- IL-31 Is Produced by the Malignant T-Cell Population in Cutaneous T-Cell Lymphoma and Correlates with CTCL Pruritus
- (2013) Elisha M. Singer et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis
- (2012) GFL Hofbauer et al. ACTA DERMATO-VENEREOLOGICA
- Substance P Signaling Controls Mast Cell Activation, Degranulation, and Nociceptive Sensitization in a Rat Fracture Model of Complex Regional Pain Syndrome
- (2012) Wen-Wu Li et al. ANESTHESIOLOGY
- Mast cells play a protumorigenic role in primary cutaneous lymphoma
- (2012) A. Rabenhorst et al. BLOOD
- Mechanistic correlations between two itch biomarkers, cytokine interleukin-31 and neuropeptide β-endorphin, via STAT3/calcium axis in atopic dermatitis
- (2012) C.-H. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Prevalence and severity of pruritus in cutaneous T cell lymphoma
- (2012) Alok Vij et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Prevalence and Severity of Pruritus and Quality of Life in Patients With Cutaneous T-Cell Lymphoma
- (2012) Abigail Wright et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Pruritus in cutaneous T-cell lymphoma: A review
- (2012) Kristen Ahern et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Aprepitant: A novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma
- (2012) Barry Ladizinski et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin
- (2012) Youn H. Kim et al. LEUKEMIA & LYMPHOMA
- Aprepitant: Evidence of its effectiveness in patients with refractory pruritus continues
- (2011) Tiago Torres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Pruritus in Cutaneous T-cell Lymphomas: Frequent, Often Severe and Difficult to Treat
- (2010) N Meyer et al. ACTA DERMATO-VENEREOLOGICA
- Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis
- (2010) P. F.-Y. Cheung et al. INTERNATIONAL IMMUNOLOGY
- Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
- (2010) Sean J. Whittaker et al. JOURNAL OF CLINICAL ONCOLOGY
- Antipruritic treatment with systemic μ-opioid receptor antagonists: A review
- (2010) Ngoc Quan Phan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dorsal horn neurons expressing NK-1 receptors mediate scratching in rats
- (2010) Earl E. Carstens et al. NEUROREPORT
- Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins
- (2009) S. Kasraie et al. ALLERGY
- Opioid-induced pruritus: an update
- (2009) A. Reich et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Microneurography of pruritus
- (2009) H.O. Handwerker NEUROSCIENCE LETTERS
- Aprepitant as an Antipruritic Agent?
- (2009) Arnaud Duval et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-31 Receptor Alpha Expression in Epidermal Keratinocytes Is Modulated by Cell Differentiation and Interferon Gamma
- (2008) Ruth Heise et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Neuropeptides activate human mast cell degranulation and chemokine production
- (2007) Marianna Kulka et al. IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started